Anavex

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Anavex and other ETFs, options, and stocks.

About AVXL

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. 

CEO
Christopher U. Missling
CEOChristopher U. Missling
Employees
25
Employees25
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2004
Founded2004
Employees
25
Employees25

AVXL Key Statistics

Market cap
841.78M
Market cap841.78M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
917.34K
Average volume917.34K
High today
$10.91
High today$10.91
Low today
$10.45
Low today$10.45
Open price
$10.75
Open price$10.75
Volume
550.84K
Volume550.84K
52 Week high
$23.73
52 Week high$23.73
52 Week low
$7.13
52 Week low$7.13

AVXL News

Simply Wall St 5d
We Think Anavex Life Sciences Can Easily Afford To Drive Business Growth - Simply Wall St

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although Amazon....

We Think Anavex Life Sciences Can Easily Afford To Drive Business Growth - Simply Wall St

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

AVXL Earnings

-$0.16
-$0.11
-$0.05
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 25, Pre-Market
ActualExpected Nov 25, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.